2013 Emerging Science Series - June 19, 2013

Updated:Jun 19,2013
ESS13_webheader

Button_Login-Register-Webinar

Cardiovascular Risk: From Epigenetics to Pharmacotherapy
Wednesday, June 19, 2013, Noon CDT


Moderators:







Robert O. Bonow, M.D., FAHA
Northwestern University Feinberg School of Medicine
Chicago, Ill.
Past AHA President and Chair of the Emerging Science Series Committee 

Christopher J. O'Donnell, M.D., MPH
National Heart, Lung and Blood Institute and NHLBI Framingham Heart Study
Framingham, MA
 
Panelists:










Neil J. Stone, M.D., FAHA, 
Feinberg School of Medicine, Northwestern University
Chicago, Ill.

Kiran Musunuru, M.D., Ph.D., M.P.H.,
Harvard University
Cambridge, Mass. 

Vasan Ramachandran M.D.,
Framingham Heart Study, Boston University
Boston, Mass.
 

Presentations:












CPT1A Methylation is a Novel Epigenetic Marker of Cardiovascular Risk 

Stella Aslibekyan, Ph.D., University of Alabama at Birmingham,  Birmingham, Ala.
Summary Slide | News Release | Abstract in Circulation | Review Article: Cardiovascular Epigenetics


The Incidence of Kidney Injury for Patients Treated with Intensive versus Less Potent Statin Therapy After an Acute Coronary Syndrome

Amy Sarma, M.D.,  Brigham and Women's Hospital, Boston, Mass.
Summary SlideNews Release | Abstract in Circulation

 
 

No CME/CE credit for this activity is provided.
 

Professional Education Center

PEC Logo
  • Register for live courses and conferences
  • Take online courses
  • Watch satellite broadcasts and webcasts
  • Listen to podcasts
  • Claim CME/CE for every event
     
Learn More button
ESS11_BannerImage

ESS11_ElliottAntmanPhotoJoin the Conversation. . .

Around the American Heart Association's Emerging Science Series and Scientific Sessions.  AHA/ASA Volunteer and Professional Member Elliott Antman, MD, FAHA, will be discussing both topics on our Professional Online Network. 

Button_LoginNow